CompletedPhase 1/2

Treatment of Laryngotracheal Stenosis Using Mesenchymal Stem Cells

Belarus12 participantsStarted 2017-01-03

Plain-language summary

The trial evaluates the safety and efficacy of the olfactory mucosa-derived mesenchymal stem cells based therapy for the patients with chronic laryngeal and tracheal stenosis

Who can participate

Age range18 Years – 85 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * confirmed diagnosis of chronic laryngeal or tracheal stenosis; * absence of cartilage damage. Exclusion Criteria: * refuse of patient to participate in the trial; * acute infectious diseases; * chronic mental disorders with severe manifestations; * pregnancy/lactation; * intercurrent severe chronic diseases; * HIV, Hepatites B/C; * active tuberculosis; * alcohol use disorder/drug addiction; * cachexia of any origin; * malignant neoplasms.

What they're measuring

Number of patients who didn't require the repeated surgical interventions

Timeframe: 1 year

Trial details

NCT IDNCT03130374

SponsorThe Republican Research and Practical Center for Epidemiology and Microbiology

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2019-01-04

View on ClinicalTrials.gov More Tracheal Stenosis trials